OBS Medical will be demonstrating BioQT, the future for Automated QT Analysis at the Cardiovascular Risk Assessment Summit. For more information come and meet us on the booth to discover the benefits BioQT can bring to your drug development trials.
OBS Medical is pleased to announce that it has successfully signed an agreement with a leading Clinical Research Organisation to use BioQT for their Thorough QT analysis trials.
A top 5 global Clinical Research Organisation has requested the opportunity to evaluate BioQT with the view to use for automated QT analysis requirements. This is based on a growing demand from the pharmaceutical industry that is recognising the benefits which can be gained from this technology.
BioQT is to be evaluated by leading global pharmaceutical company. Results to be released in 2012.
OBS Medical Ltd, the patient monitoring systems company, is pleased to announce the following changes to the Board of Directors.
Richard Moon, Chairman and Non-Executive Director and Allan Cockell, Non-Executive Director, are retiring from Board with immediate effect.
OBS Medical Ltd, today announced that Visensia has received 510k clearance from the FDA. This is the fourth 510k clearance for Visensia since the original introduction of Visensia (Originally known as BioSignTM) in 2005. Visensia was the first FDA cleared patient health index device with alerts on the market and is continuing to develop innovative leading edge products.
OBS Medical and t+ Medical Ltd presents the project Help4Mood, a significant advance in supporting the recovery of people with major depression at home. The project is funded by the European Union’s Seventh Framework Programme, has a budget of around 3 million euros.
OBS will be attending the following trade shows this year:
OBS Medical Celebrates 10 Years of Business
These companies with origins in Oxford University, have come together in a long anticipated merger
Radio and website Interviews with the team at Oxford who are using t+ blood pressure lite.
t+ Medical today announces that it has launched its new product t+ blood pressure lite.
t+ Medical are taking the easy option this year, and have sponsored someone else do the hard work and raise funds for Diabetes UK.
OBS Medical’s BIOQT™ technology has been recognized as a top finalist for the prestigious TechPoint Mira Award “Healthcare IT Innovation Award”.
Congratulations to Trudy Kuipers–de Groot of Astellas Pharma.
An ipod touch will be with you shortly…
Commiserations to all those who entered but did not win.